Keywords: somaxon, gets, american, rights, biotie, oral, nalmefene

Somaxon gets N American rights to Biotie's oral nalmefene

Article | 22 November 2004

Print This

San Diego, USA-based Somaxon Pharmaceuticals says it has licensed the North American rights to oral nalmefene hydrochloride from Finnish drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in